Language:

Results 21 - 40 of 245 for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method

1 Results 2 3 4 5

Refined by: Database: Freely Accessible Japanese Titles

Database: Wiley_OA刊

Result Number	Material Type	Record Details and Options
21	Material Type: Article	Abemaciclib in combination with endocrine therapy for East Asian patients with HR+, HER2− advanced breast cancer: MONARCH 2 & 3 trials Cancer science, 2021-06, Vol.112 (6), p.2381-2392 [Peer Reviewed Journal] 2021 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2021 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;COPYRIGHT 2021 John Wiley & Sons, Inc. ;2021. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.14877 ;PMID: 33686753 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
22	Material Type: Article	Phase I study of the irreversible fibroblast growth factor receptor 1–4 inhibitor futibatinib in Japanese patients with advanced solid tumors Cancer science, 2023-02, Vol.114 (2), p.574-585 [Peer Reviewed Journal] 2022 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2022 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2023. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.15486 ;PMID: 35838190 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
23	Material Type: Article	Molecular pathology quality control in Southeast Asia: Results of a multiregional quality assurance study from MASTER KEY Asia Cancer science, 2023-06, Vol.114 (6), p.2664-2673 [Peer Reviewed Journal] 2023 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2023 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2023. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.15790 ;PMID: 36919757 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
24	Material Type: Article	Phase I study of tivantinib in Japanese patients with advanced hepatocellular carcinoma: Distinctive pharmacokinetic profiles from other solid tumors Cancer science, 2015-05, Vol.106 (5), p.611-617 [Peer Reviewed Journal] 2015 The Authors. Cancer Science published by Wiley Publishing Asia Pty Ltd on behalf of Japanese Cancer Association. ;2015. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2015 The Authors. Cancer Science published by Wiley Publishing Asia Pty Ltd on behalf of Japanese Cancer Association. 2015 ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.12644 ;PMID: 25711511 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
25	Material Type: Article	Efficacy and safety of nivolumab in Japanese patients with previously untreated advanced melanoma: A phase II study Cancer science, 2017-06, Vol.108 (6), p.1223-1230 [Peer Reviewed Journal] 2017 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2017 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2017. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.13241 ;PMID: 28342215 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
26	Material Type: Article	Mitochondrial DNA haplogroup M7: A predictor of poor prognosis for colorectal cancer patients in Chinese population Cancer science, 2023-03, Vol.114 (3), p.1056-1066 [Peer Reviewed Journal] 2022 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2022 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2023. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.15654 ;PMID: 36382493 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
27	Material Type: Article	Network analysis of the depressive symptom profiles in Asian patients with depressive disorders: Findings from the Research on Asian Psychotropic Prescription Patterns for Antidepressants (REAP‐AD) Psychiatry and clinical neurosciences, 2020-06, Vol.74 (6), p.344-353 [Peer Reviewed Journal] 2020 The Authors. Psychiatry and Clinical Neurosciences published by John Wiley & Sons Australia, Ltd on behalf of Japanese Society of Psychiatry and Neurology ;2020 The Authors. Psychiatry and Clinical Neurosciences published by John Wiley & Sons Australia, Ltd on behalf of Japanese Society of Psychiatry and Neurology. ;2020. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1323-1316 ;EISSN: 1440-1819 ;DOI: 10.1111/pcn.12989 ;PMID: 32048773 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
28	Material Type: Article	KEYNOTE‐025: Phase 1b study of pembrolizumab in Japanese patients with previously treated programmed death ligand 1–positive advanced non–small‐cell lung cancer Cancer science, 2019-03, Vol.110 (3), p.1012-1020 [Peer Reviewed Journal] 2019 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2019 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2019. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.13932 ;PMID: 30618179 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
29	Material Type: Article	Phase 1 trial of zolbetuximab in Japanese patients with CLDN18.2+ gastric or gastroesophageal junction adenocarcinoma Cancer science, 2023-04, Vol.114 (4), p.1606-1615 [Peer Reviewed Journal] 2022 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2022 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2023. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.15684 ;PMID: 36478334 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
30	Material Type: Article	Comprehensive genomic profiling of lung cancer using a validated panel to explore therapeutic targets in East Asian patients Cancer science, 2017-12, Vol.108 (12), p.2487-2494 [Peer Reviewed Journal] 2017 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2017 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2017. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.13410 ;PMID: 28949084 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
31	Material Type: Article	Low‐carbohydrate diet and risk of cancer incidence: The Japan Public Health Center‐based prospective study Cancer science, 2022-02, Vol.113 (2), p.744-755 [Peer Reviewed Journal] 2021 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2021 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2022. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.15215 ;PMID: 34821435 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
32	Material Type: Article	Afatinib versus cisplatin plus pemetrexed in Japanese patients with advanced non‐small cell lung cancer harboring activating EGFR mutations: Subgroup analysis of LUX‐Lung 3 Cancer science, 2015-09, Vol.106 (9), p.1202-1211 [Peer Reviewed Journal] 2015 The Authors. Cancer Science published by Wiley Publishing Asia Pty Ltd on behalf of Japanese Cancer Association. ;2015. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2015 The Authors. Cancer Science published by Wiley Publishing Asia Pty Ltd on behalf of Japanese Cancer Association. 2015 ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.12723 ;PMID: 26094656 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
33	Material Type: Article	Efficacy and safety of nivolumab in Japanese patients with advanced or recurrent squamous non‐small cell lung cancer Cancer science, 2017-05, Vol.108 (5), p.1000-1006 [Peer Reviewed Journal] 2017 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2017. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.13225 ;PMID: 28266091 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
34	Material Type: Article	Genomic landscape and its prognostic significance in stage III colorectal cancer: JCOG1506A1, an ancillary of JCOG0910 Cancer science, 2023-08, Vol.114 (8), p.3352-3363 [Peer Reviewed Journal] 2023 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2023 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2023. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.15834 ;PMID: 37189003 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
35	Material Type: Article	Ribociclib, a CDK 4/6 inhibitor, plus endocrine therapy in Asian women with advanced breast cancer Cancer science, 2020-09, Vol.111 (9), p.3313-3326 [Peer Reviewed Journal] 2020 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association ;2020. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.14554 ;PMID: 32619077 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
36	Material Type: Article	Adjuvant atezolizumab in Japanese patients with resected stage IB‐IIIA non‐small cell lung cancer (IMpower010) Cancer science, 2022-12, Vol.113 (12), p.4327-4338 [Peer Reviewed Journal] 2022 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2022 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2022. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.15564 ;PMID: 36062851 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
37	$Multicenter phase II study of nivolumab in Japanese patients with relapsed or refractory classical Hodgkin lymphoma$ $Multicenter phase II study of nivolumab in Japanese patients with relapsed or refractory classical Hodgkin lymphoma$ Material Type: Article	Multicenter phase II study of nivolumab in Japanese patients with relapsed or refractory classical Hodgkin lymphoma Cancer science, 2017-05, Vol.108 (5), p.1007-1012 [Peer Reviewed Journal] 2017 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2017. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.13230 ;PMID: 28267244 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
38	Material Type: Article	Pembrolizumab plus chemotherapy in Japanese patients with metastatic squamous non‐small‐cell lung cancer in KEYNOTE‐407 Cancer science, 2023-08, Vol.114 (8), p.3330-3341 [Peer Reviewed Journal] 2023 Merck Sharp & Dohme LLC and The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2023 Merck Sharp & Dohme LLC and The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2023. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.15816 ;PMID: 37183528 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
39	Material Type: Article	Development and validation of the Japanese version of the Athens Insomnia Scale Psychiatry and clinical neurosciences, 2013-09, Vol.67 (6), p.420-425 [Peer Reviewed Journal] 2013 The Authors. Psychiatry and Clinical Neurosciences © 2013 Japanese Society of Psychiatry and Neurology ;2015 INIST-CNRS ;2013 The Authors. Psychiatry and Clinical Neurosciences © 2013 Japanese Society of Psychiatry and Neurology. ;ISSN: 1323-1316 ;EISSN: 1440-1819 ;DOI: 10.1111/pcn.12073 ;PMID: 23910517 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
40	Material Type: Article	Long‐term follow up of nivolumab in previously untreated Japanese patients with advanced or recurrent malignant melanoma Cancer science, 2019-06, Vol.110 (6), p.1995-2003 [Peer Reviewed Journal] 2019 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2019 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;Copyright John Wiley & Sons, Inc. Jun 2019 ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.14015 ;PMID: 30959557 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by